Skip to content

Preventive effect of Lidocaine-prilocaine (EMLA) cream on catheter-related bladder discomfort of male patients in post-anesthesia care unit

Preventive effect of Lidocaine-prilocaine (EMLA) cream on catheter-related bladder discomfort of male patients in post-anesthesia care unit

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15007017
Enrollment
Unknown
Registered
2015-08-31
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-related bladder discomfort

Interventions

EMLA group and control group:use or no use EMLA

Sponsors

Tianjin Union Medical center
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
23 Years to 83 Years

Inclusion criteria

Inclusion criteria: Patients aged 23 to 83 years who were American Society of Anesthesiologists (ASA) physical status I-III and scheduled to undergo elective surgery were included in this study. These patients were scheduled to perform a urinary catheterization after anesthesia induction.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had a history of hypersensitivity to lidocaine or prilocaine, conduction disturbance, cognitive deficit, intellectual disability, or long-term use of analgesics or sedatives medication; chronic renal insufficiency (creatinine >1.5 mg/dL) or liver insufficiency (bilirubin >34.2 umol/L); benign prostatic hyperplasia, overactive bladder, neurogenic bladder, or had a history of allergy to opiates or any other drug used in the study. Pelvic procedures such as urogenital surgery, proctectomy were excluded.

Design outcomes

Primary

MeasureTime frame
the incidence and severe of CRBD;

Countries

China

Contacts

Public ContactLi-cheng Geng
cd105mn@sina.com+86 15522976186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026